T. Kris Eckols

936 total citations
18 papers, 633 citations indexed

About

T. Kris Eckols is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, T. Kris Eckols has authored 18 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in T. Kris Eckols's work include Cytokine Signaling Pathways and Interactions (10 papers), Cancer Mechanisms and Therapy (3 papers) and Tuberculosis Research and Epidemiology (2 papers). T. Kris Eckols is often cited by papers focused on Cytokine Signaling Pathways and Interactions (10 papers), Cancer Mechanisms and Therapy (3 papers) and Tuberculosis Research and Epidemiology (2 papers). T. Kris Eckols collaborates with scholars based in United States, China and Greece. T. Kris Eckols's co-authors include David J. Tweardy, Moses M. Kasembeli, Uddalak Bharadwaj, Mikhail Kolosov, Wilson Chun Yu Lau, Judith Frydman, Wah Chiu, Soung‐Hun Roh, Prema Robinson and Stephen Y. Lai and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

T. Kris Eckols

18 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Kris Eckols United States 13 334 262 116 82 75 18 633
Yoshiyuki Yabe Japan 11 270 0.8× 184 0.7× 60 0.5× 100 1.2× 82 1.1× 18 638
Madhavi Sekharam United States 11 452 1.4× 328 1.3× 112 1.0× 43 0.5× 133 1.8× 14 789
Minsoo Koh South Korea 13 391 1.2× 178 0.7× 41 0.4× 37 0.5× 128 1.7× 17 717
Stephanie Deangelis United States 9 466 1.4× 500 1.9× 196 1.7× 41 0.5× 124 1.7× 10 865
Paul Shapiro United States 18 469 1.4× 124 0.5× 75 0.6× 34 0.4× 49 0.7× 31 669
Chengjuan Chen China 17 281 0.8× 132 0.5× 64 0.6× 68 0.8× 118 1.6× 30 659
Wanghai Zhang United States 11 387 1.2× 249 1.0× 68 0.6× 75 0.9× 40 0.5× 16 683
Wu-Ming Qin China 9 340 1.0× 159 0.6× 56 0.5× 57 0.7× 36 0.5× 13 571
Begoña Cánovas Spain 6 432 1.3× 125 0.5× 63 0.5× 22 0.3× 76 1.0× 8 677
Xavier Billot Canada 7 463 1.4× 152 0.6× 55 0.5× 40 0.5× 79 1.1× 10 769

Countries citing papers authored by T. Kris Eckols

Since Specialization
Citations

This map shows the geographic impact of T. Kris Eckols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Kris Eckols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Kris Eckols more than expected).

Fields of papers citing papers by T. Kris Eckols

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Kris Eckols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Kris Eckols. The network helps show where T. Kris Eckols may publish in the future.

Co-authorship network of co-authors of T. Kris Eckols

This figure shows the co-authorship network connecting the top 25 collaborators of T. Kris Eckols. A scholar is included among the top collaborators of T. Kris Eckols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Kris Eckols. T. Kris Eckols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Robinson, Prema, Emma Rodrı́guez, Yang Peng, et al.. (2023). Therapeutic Potential of a Small-Molecule STAT3 Inhibitor in a Mouse Model of Colitis. Cancers. 15(11). 2977–2977. 8 indexed citations
2.
Robinson, Prema, et al.. (2022). Genetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn’s Disease. Journal of Clinical Medicine. 11(23). 7020–7020. 8 indexed citations
3.
Kong, Ren, Uddalak Bharadwaj, T. Kris Eckols, et al.. (2021). Novel STAT3 small-molecule inhibitors identified by structure-based virtual ligand screening incorporating SH2 domain flexibility. Pharmacological Research. 169. 105637–105637. 14 indexed citations
4.
Rodrı́guez, Emma, et al.. (2021). Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity. Cancers. 13(7). 1732–1732. 20 indexed citations
5.
Kettner, Nicole M., Tuyen Bui, Min Jin Ha, et al.. (2020). Abstract P6-04-12: STAT3 as a therapeutic target in estrogen receptor positive breast cancer patients refractory to CDK4/6 inhibition. Cancer Research. 80(4_Supplement). P6–4. 1 indexed citations
6.
Zhang, Ping, Ying Wang, Yanlan Dong, et al.. (2020). Pharmacokinetics and pharmacodynamics of TTI-101, a STAT3 inhibitor that blocks muscle proteolysis in rats with chronic kidney disease. American Journal of Physiology-Renal Physiology. 319(1). F84–F92. 20 indexed citations
7.
Eckols, T. Kris, et al.. (2019). Selective Small Molecule STAT3 Inhibitor to Treat Eosinophilic and Neutrophilic Asthma in Mice. A7298–A7298. 1 indexed citations
8.
Kong, Ren, Uddalak Bharadwaj, T. Kris Eckols, et al.. (2019). Abstract 17: Novel STAT3 inhibitors identified by Structure-Based Virtual Ligand Screening incorporating SH2 domain flexibility. 17–17. 1 indexed citations
9.
Jung, Kwang Hwa, Wonbeak Yoo, Heather L. Stevenson, et al.. (2017). Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice. Clinical Cancer Research. 23(18). 5537–5546. 98 indexed citations
10.
Bharadwaj, Uddalak, T. Kris Eckols, Xuejun Xu, et al.. (2016). Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma. Oncotarget. 7(18). 26307–26330. 87 indexed citations
11.
Lewis, Katherine, Uddalak Bharadwaj, T. Kris Eckols, et al.. (2015). Small-molecule targeting of signal transducer and activator of transcription (STAT) 3 to treat non-small cell lung cancer. Lung Cancer. 90(2). 182–190. 46 indexed citations
12.
Bharadwaj, Uddalak, T. Kris Eckols, Mikhail Kolosov, et al.. (2014). Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer. Oncogene. 34(11). 1341–1353. 137 indexed citations
13.
Kasembeli, Moses M., Wilson Chun Yu Lau, Soung‐Hun Roh, et al.. (2014). Modulation of STAT3 Folding and Function by TRiC/CCT Chaperonin. PLoS Biology. 12(4). e1001844–e1001844. 80 indexed citations
14.
Kolosov, Mikhail, et al.. (2014). Synthetic and Biological Studies of Phaeosphaerides. The Journal of Organic Chemistry. 79(9). 4043–4054. 24 indexed citations
15.
Bharadwaj, Uddalak, Moses M. Kasembeli, T. Kris Eckols, et al.. (2014). Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer. Cancers. 6(4). 2012–2034. 16 indexed citations
16.
Robinson, Prema, et al.. (2009). Substance P is required for the pathogenesis of EMCV infection in mice.. PubMed. 2(1). 76–86. 33 indexed citations
17.
Carpenter, John W., Carmen Laethem, T. Kris Eckols, et al.. (2003). Configuring Radioligand Receptor Binding Assays for HTS Using Scintillation Proximity Assay Technology. Humana Press eBooks. 190. 31–49. 15 indexed citations
18.
Eckols, T. Kris, Richard E. Thompson, & Ruthann A. Masaracchia. (1983). Primary Substrate Specificity Determinants for the H4‐Specific Protease‐Activated Protein Phosphotransferase. European Journal of Biochemistry. 134(2). 249–254. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiyuki Yabe Breakdown of academic impact, for papers by Madhavi Sekharam Breakdown of academic impact, for papers by Minsoo Koh Breakdown of academic impact, for papers by Stephanie Deangelis Breakdown of academic impact, for papers by Paul Shapiro Breakdown of academic impact, for papers by Chengjuan Chen Breakdown of academic impact, for papers by Wanghai Zhang Breakdown of academic impact, for papers by Wu-Ming Qin Breakdown of academic impact, for papers by Begoña Cánovas Breakdown of academic impact, for papers by Xavier Billot
Rankless by CCL
2026